Helen Frankenthaler Foundation

GLP-1R detection reagent supplier

GLP-2 (1-33) (human) Product Details

GLP-2 (1-33) (human)

H-His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-OH

Product Information

Product Number: 4039611

CAS Number: 223460-79-5

Pack Size Selection

Pack size available

  • 0.5mg
  • 1mg

PLEASE SELECT PACK SIZE:

  • 0.5mg (CHF 224.70)
  • 1mg (CHF 404.50)

Clear

GLP-2 (1-33) (human) quantity

Add to your inquiry

PRODUCT DESCRIPTION

Like GLP-1, GLP-2 is secreted from enteroendocrine cells in a nutrient-dependent manner in both rodents and humans. Currently GLP-2 is used as a potential therapeutic agent for human subjects with a broad variety of intestinal diseases characterized by intestinal damage and insufficiency.

Additional Information

  • ADS/MSDS
  • Materials
  • Literature
Specifications

Salt form: Trifluoroacetate

Molecular weight: 3766.16

Chemical Formula: C₁₆₅H₂₅₄N₄₄O₅₅S

Storage Temperature: < -15°C

Synonyms: Preproglucagon (146-178) (human)

One Letter code: HADGSFSDEMNTILDNLAARDFINWLIQTKITD

Source: Synthetic

Old Product Number: H-5662

COUNTRY

Argentina Australia Austria Belgium Brazil Bulgaria Canada Chile China Colombia Croatia Cyprus Czech Republic Denmark Ecuador Egypt Estonia Finland France Germany Greece Guadeloupe Hong Kong Iceland India Indonesia Iran Iraq Ireland Israel Italy Japan Jordan Kenya Kuwait Latvia Lebanon Liechtenstein Lithuania Luxembourg Macao Malaysia Mauritius Mexico Montenegro Netherlands New Zealand Nigeria Norway Pakistan Papua New Guinea Peru Philippines Poland Portugal Puerto Rico Romania Russia Serbia Singapore Slovakia Slovenia South Africa South Korea Spain Sweden Switzerland Taiwan Thailand Türkiye United Arab Emirates United Kingdom (UK) United States (US) Uruguay Other countries

INQUIRY LIST

No products in the list

Site Links

SPECIAL OFFERS FAQS ADS LOOKUP MSDS LOOKUP KNOWLEDGE CENTER KNOWLEDGE CENTER GENERAL CONDITIONS LEGAL STATEMENT PRIVACY POLICY IMPRINT CONTACT